Enthera Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $42.6M

  • Investors
  • 10

Enthera General Information

Description

Developer of biotherapeutics intended to treat auto-immune disorders. The company's pipelined products target pathways involved in cell apoptosis in the gut, pancreas, and other organs which plays a key role in the development of type 1 diabetes and inflammatory bowel disease, enabling the medical community to effectively combat intractable autoimmune diseases.

Contact Information

Website
www.entherapharmaceuticals.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan(Lombardy)
  • Italy
+39 02 0000 0000
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Via Visconti di Modrone, 18
  • 20122 Milan(Lombardy)
  • Italy
+39 02 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enthera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 28-Jan-2021 $42.6M 000.00 Completed Clinical Trials - Phase 1
3. Seed Round 24-Jul-2018 00.000 00.000 Completed Pre-Clinical Trials
2. Early Stage VC 10-May-2018 Completed Pre-Clinical Trials
1. Seed Round 01-Oct-2016 Completed Pre-Clinical Trials
To view Enthera’s complete valuation and funding history, request access »

Enthera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotherapeutics intended to treat auto-immune disorders. The company's pipelined products target pathways i
Drug Discovery
Milan, Italy
15 As of 2024
000.00
00000000000 000.00

000000

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 000000000
Cambridge, MA
000
00000000000 000

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
La Jolla, CA
00 As of 0000
000.00
00000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enthera Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Venture Capital-Backed Cambridge, MA 000 00000000000 000
Equillium Formerly VC-backed La Jolla, CA 00 000.00 00000000 000.00
Minerva Neurosciences Formerly VC-backed Burlington, MA 0 00000 000000000 00000
Metabolic Solutions Development Venture Capital-Backed Kalamazoo, MI 00 0000 000000 - 000 0000
Iconic Therapeutics Formerly VC-backed South San Francisco, CA 0 00000 000000&0 00000
You’re viewing 5 of 31 competitors. Get the full list »

Enthera Patents

  • 15

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 13

    Pending

  • 000

    Expiring in next 12 mo

Enthera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021225061-A1 Inhibitors and uses thereof Pending 20-Feb-2020 000000000
CA-3162043-A1 Antibody inhibitors of igfbp5 Pending 20-Feb-2020 000000000
EP-4106804-A1 Inhibitors and uses thereof Pending 20-Feb-2020 000000000
EP-3868396-A1 Inhibitors and uses thereof Inactive 20-Feb-2020 000000000 00
US-20230192827-A1 Inhibitors and uses thereof Pending 20-Feb-2020 C07K16/18
To view Enthera’s complete patent history, request access »

Enthera Executive Team (10)

Name Title Board Seat
Lisa Olson Ph.D Chief Executive Officer
Lucia Reggi Financial Director
Francesca D'Addio Ph.D Co-Founder, Head of Preclinical Research, and Scientific Advisor
Silvano Spinelli Co-Founder & Chairman
Filippo Canducci Chief Medical Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Enthera Board Members (12)

Name Representing Role Since
Anta Gkelou Ph.D Sofinnova Partners Board Observer 000 0000
Carole Nuechterlein JD Roche Venture Fund Board Member 000 0000
Christian Schubert Ph.D AbbVie Ventures Board Member 000 0000
Graziano Seghezzi Sofinnova Partners Board Member 000 0000
Jasmina Marjanovic Ph.D AbbVie Ventures Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Enthera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enthera Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Banca Profilo Asset Manager Minority 000 0000 000000 0
Banor Sim Family Office Minority 000 0000 000000 0
Landmark Capital (Italy) Family Office Minority 000 0000 000000 0
Roche Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Enthera FAQs

  • When was Enthera founded?

    Enthera was founded in 2016.

  • Who is the founder of Enthera?

    Francesca D'Addio Ph.D, Silvano Spinelli, Paolo Fiorina MD, and Maria Camboni MD are the founders of Enthera.

  • Who is the CEO of Enthera?

    Lisa Olson Ph.D is the CEO of Enthera.

  • Where is Enthera headquartered?

    Enthera is headquartered in Milan, Italy.

  • What is the size of Enthera?

    Enthera has 15 total employees.

  • What industry is Enthera in?

    Enthera’s primary industry is Drug Discovery.

  • Is Enthera a private or public company?

    Enthera is a Private company.

  • What is Enthera’s current revenue?

    The current revenue for Enthera is 00000.

  • How much funding has Enthera raised over time?

    Enthera has raised $47.2M.

  • Who are Enthera’s investors?

    AbbVie Ventures, Banca Profilo, Banor Sim, Landmark Capital (Italy), and Roche Venture Fund are 5 of 10 investors who have invested in Enthera.

  • Who are Enthera’s competitors?

    AnTolRx, Equillium, Minerva Neurosciences, Metabolic Solutions Development, and Iconic Therapeutics are some of the 31 competitors of Enthera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »